COPD: antiplatelet therapy and all-cause mortality | COPD

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Antiplatelet therapy in chronic obstructive pulmonary disease (COPD) may significantly lower all-cause mortality.

 

Study design/methods

  • Literature search identified 5 studies including 11117 COPD patients (3069 with acute exacerbation; 33% with ischemic heart disease [IHD])...